Annovis Bio, Inc. Operating Income Loss

• Annovis Bio, Inc. showed a decrease of -11.2% in Operating Income Loss from 2024 to 2025.
• This data is from Annovis Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Annovis Bio, Inc.'s Operating Income Loss has declined by 1,749.5%.
• Historical annual values: Fiscal year 2025: -$29.70 million | Fiscal year 2024: -$26.69 million | Fiscal year 2023: -$45.04 million | Fiscal year 2022: -$25.51 million | Fiscal year 2021: -$14.54 million | Fiscal year 2020: -$6.64 million | Fiscal year 2019: -$1.61 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026